Drugs

Drug Shortages: Additional Information

Drug NameCompany InformationRelated Information
Lactated Ringer's Injection USP, 1000 mL
(NDC 0264-7750-00)
B. Braun Medical Inc.
800-227-2862
BBraun Customer Letter IV Solution Shortage
Metronidazole Injection USP 500 mg (5 mg/mL), 100 mL (NDC 0264-5535-32)B. Braun Medical Inc.
800-227-2862
BBraun Customer Letter IV Solution Shortage
5% Dextrose Injection USP, 25 mL (NDC 0264-1510-36)B. Braun Medical Inc.
800-227-2862
BBraun Customer Letter IV Solution Shortage
5% Dextrose Injection USP, 50 mL (NDC 0264-1510-31)B. Braun Medical Inc.
800-227-2862
BBraun Customer Letter IV Solution Shortage
5% Dextrose Injection USP, 100 mL (NDC 0264-1510-32)B. Braun Medical Inc.
800-227-2862
BBraun Customer Letter IV Solution Shortage
0.9% Sodium Chloride Injection USP, 25 mL (NDC 0264-1800-36)B. Braun Medical Inc.
800-227-2862
BBraun Customer Letter IV Solution Shortage
0.9% Sodium Chloride Injection USP, 50 mL (NDC 0264-1800-36)0.9% Sodium Chloride Injection USP, 50 mL (NDC 0264-1800-36) B. Braun Medical Inc.
800-227-2862
BBraun Customer Letter IV Solution Shortage
0.9% Sodium Chloride Injection USP, 100 mL (NDC 0264-1800-32)B. Braun Medical Inc.
800-227-2862
BBraun Customer Letter IV Solution Shortage

Potassium Acetate 40 meq/20mL (2 meq/mL) Injection
(NDC 51754-2001-4)

 

Applicant: Exela Pharma Sciences, (888) 451-4321Product is available through direct orders. (888) 451-4321
The current carton and vial labels for Exela’s Potassium Acetate 40 meq/20 mL (2 meq/mL) Injection indicate the product contains an aluminum level of not more than 200 mcg/L.  We have determined that the actual aluminum level in some instances may exceed 200 mcg/L in the product. See attached DHCP letter for information.
Sodium Phosphates Injection, USP

45 mM P/15 mL (3 mM P/mL); 60 mEq Na+ /15mL (4.0 mEq/mL)

NDC 0409‐7391‐72
Hospira, Inc.

Company Contact Information: 844-646-4398
Correction to osmolarity concentration on Sodium Phosphates Injections, USP labeling. Sodium Phosphates Notification Letter
Potassium Phosphates Injection, USP

45 mM P/15 mL (3 mM P/mL); 66 mEq K+ /15mL (4.4 mEq/mL)

NDC 0409‐7295‐01
Hospira, Inc.

Company Contact Information: 844-646-4398
Correction to osmolarity concentration on Potassium Phosphates Injections, USP labeling. Potassium Phosphates Notification Letter
Alkeran (Melphalan) 2 MG Tablets;
Bottle of 50
(NDC 52609-0001-5)
 
Applicant: Apotex Inc, (416) 749-9300
  • Product is available.
  • Additional Alkeran tablets batches will be released to market before end of Jan 2017.
  • Customers seeking product should call ApoPharma customer service number 1-866-931-0740 
     
PRIALT® (ziconotide) Solution, Intrathecal Infusion
25 mcg/mL PRIALT in 20 mL vial  (NDC# 18860-0723-10)
Jazz Pharmaceuticals, Inc.
1‐800‐520‐5568
PRIALT® (ziconotide) Solution, Intrathecal Infusion is provided in the US in three presentations:
  • 100 mcg/mL PRIALT in 1 mL vials (NDC# 18860-0720-10) – Currently Available
  • 100 mcg/mL PRIALT in 5 mL vials (NDC# 18860-0722-10) – Currently Available
  • 25 mcg/mL PRIALT in 20 mL vials  (NDC# 18860-0723-10) – Currently Out of Stockdisclaimer icon

Sacrosidase Oral Solution, 8500 IU/mL,
2x118 mL bottle (NDC# 67871-111-04)

Updated 7/27/17

QOL Medical, LLC

1-866-469-3773

Limited Supply Available

 

Page Last Updated: 08/28/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English